Decoy receptor 3 (DcR3) modulates resistance to platinum in epithelial ovarian cancer via Heparan Sulfate Proteoglycans (HSPGs).

被引：0
|
作者：
Connor, Joseph [1 ]
Felder, Mildred [1 ]
Patankar, Manish [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2958
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance
    C Palmieri
    O Gojis
    B Rudraraju
    C Stamp-Vincent
    D Wilson
    S Langdon
    C Gourley
    D Faratian
    British Journal of Cancer, 2013, 108 : 2039 - 2044
  • [42] Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo
    Zhou, Jian
    Song, Shiduo
    He, Songbin
    Wang, Zhenxin
    Zhang, Bing
    Li, Dechun
    Zhu, Dongming
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 (03) : 653 - 660
  • [43] The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid
    Mueller, Andre M.
    Pedre, Xiomara
    Killian, Stephan
    David, Monique
    Steinbrecher, Andreas
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 209 (1-2) : 57 - 64
  • [44] Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis
    Bamias, Giorgos
    Siakavellas, Spyros I.
    Stamatelopoulos, Kimon S.
    Chryssochoou, Elda
    Papamichalel, Christos
    Sfikakis, Petros P.
    CLINICAL IMMUNOLOGY, 2008, 129 (02) : 249 - 255
  • [45] PACSIN3 is a novel biomarker for platinum resistance BRCA mutated platinum resistance epithelial ovarian cancer.
    Han, Gwan Hee
    Cho, Hanbyoul
    Yun, Hee
    Kim, Jae-Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17540 - E17540
  • [46] Genomic DNA amplification of decoy receptor 3 (DcR3) is an important prognostic factor in ER-negative breast cancer patients by tree-structured survival analysis.
    Koyama, Y.
    Valera, V.
    Kanbayashi, C.
    Yoshizawa, M.
    Fujita, K.
    Kaneko, K.
    Hatakeyama, K.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S263 - S263
  • [47] Notch receptor signaling mediates platinum and paclitaxel resistance in epithelial ovarian cancer
    Park, Y. H.
    Seoung, J.
    Kim, H. B.
    Kyung, M. S.
    Rhim, C. C.
    Min, S.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 206 - 206
  • [48] GSK3β modulates chemoresistance in epithelial ovarian cancer
    Pathak, Naeha
    Cutter, Noelle L.
    CANCER RESEARCH, 2016, 76
  • [49] Gene expression profiles of TNF-like cytokine 1A (TL1A) and its receptors death receptor 3 (DR3) and decoy receptor 3 (DcR3) in multiple sclerosis
    Basnyat, Pabitra
    Sumelahti, Marja-Liisa
    Lehtimaki, Terho
    Elovaara, Irina
    Hagman, Sanna
    JOURNAL OF NEUROIMMUNOLOGY, 2019, 335
  • [50] SERPINB3 in the Chicken Model of Ovarian Cancer: A Prognostic Factor for Platinum Resistance and Survival in Patients with Epithelial Ovarian Cancer
    Lim, Whasun
    Kim, Hee Seung
    Jeong, Wooyoung
    Ahn, Suzie E.
    Kim, Jinyoung
    Kim, Yong Beom
    Kim, Min A.
    Kim, Mi-Kyung
    Chung, Hyun Hoon
    Song, Yong Sang
    Bazer, Fuller W.
    Han, Jae Yong
    Song, Gwonhwa
    PLOS ONE, 2012, 7 (11):
12345